Form 4 · Statement of Changes in Beneficial Ownership · Filed 2025-11-05
Stryker Ronda E Files Stryker (SYK) Form 4 - November 05, 2025
Stryker Ronda E sold 520.0K SYK shares worth $184.6M in this Form 4 filing, reported to the SEC on 2025-11-05.
- Insider
- Stryker Ronda E
- Issuer
- Stryker Corporation SYK · NYSE
- Filed
- Period
- 2025-11-05
- Accession
- 0001242914-25-000006
- Source
- Official filing on sec.gov ↗
Transactions (14)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Stryker Ronda E | 2025-11-06 | Sell | 1.8K | $355.80 | $624.1K | Indirect |
| Stryker Ronda E | 2025-11-06 | Sell | 396 | $349.95 | $138.6K | Indirect |
| Stryker Ronda E | 2025-11-06 | Sell | 3.8K | $351.30 | $1.3M | Indirect |
| Stryker Ronda E | 2025-11-06 | Sell | 68.1K | $352.45 | $24.0M | Indirect |
| Stryker Ronda E | 2025-11-06 | Sell | 141.1K | $353.17 | $49.8M | Indirect |
| Stryker Ronda E | 2025-11-06 | Sell | 36.4K | $354.13 | $12.9M | Indirect |
| Stryker Ronda E | 2025-11-06 | Sell | 24.7K | $355.10 | $8.8M | Indirect |
| Stryker Ronda E | 2025-11-05 | Sell | 20.0K | $354.13 | $7.1M | Indirect |
| Stryker Ronda E | 2025-11-05 | Sell | 22.4K | $354.94 | $7.9M | Indirect |
| Stryker Ronda E | 2025-11-05 | Sell | 29.4K | $356.16 | $10.5M | Indirect |
| Stryker Ronda E | 2025-11-05 | Sell | 67.9K | $357.06 | $24.2M | Indirect |
| Stryker Ronda E | 2025-11-05 | Sell | 72.2K | $357.89 | $25.8M | Indirect |
| Stryker Ronda E | 2025-11-05 | Sell | 31.8K | $358.68 | $11.4M | Indirect |
| Stryker Ronda E | 2025-11-05 | Sell | 180 | $359.79 | $64.8K | Indirect |
| Net change | −520.0K | −$184.6M | ||||
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Track SYK insider activity
Get alerted when Stryker Corporation executives buy or sell their shares.